Fig. 7From: SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney diseaseThe metabolic network for the key pathways in the renoprotection effect of Empa in db/db mice. The background color for each pathway represents the active state after Empa intervention. Yellow, elevated activity after Empa intervention; Blue, decreased activity after Empa intervention. The color of the box below each metabolites represents the log2 (fold change) of this metabolite between db/db and db/m or Empa and db/db group. ‘a’, the serotonin metabolism pathway; ‘b’, the indole pathway; ‘c’, the kynurenine pathway; ‘d’, NAD+ de novo synthesis pathway; ‘e’, the salvage synthesis pathway of NAD+; ‘f’, purine degradation pathway; ‘g’, ATP-degradation mediated purine nucleotide conversion bypass; ‘h’, pyrimidine de novo synthesis pathwayBack to article page